Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/lung-cancer-screening/descriptif_4933580
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=4933580

Lung Cancer Screening , 1st ed. 2023 A Population Approach

Langue : Anglais

Coordonnateurs : Kane Gregory C., Barta Julie A., Myers Ronald E., Evans III Nathaniel R.

This book is a comprehensive guide to lung cancer screening for clinicians, healthcare systems, community leaders, and public health officials with the hope of creating a more equitable landscape in both lung cancer screening and lung cancer-related outcomes, at local, state, and national levels. Authors take a new approach to primary and secondary lung cancer prevention that is in the early stages of adoption in the United States. The last decade ushered in recognition of screening as an effective intervention, but unfortunately, despite the wide acceptance of the importance of this new screening modality, nationally, not more than 5% of eligible subjects have undergone screening to date in the United States, although in some states uptake has reached as high as 16%. As is common with any new preventive cancer screening, racial and socioeconomic disparities emerge in utilization, stage at diagnosis, and mortality. Over time, these disparities decline, but consequential differences endure. Therefore, it is critical to establish equitable screening practices. 

The true measure of the effectiveness of any lung cancer screening program needs to be viewed through the lens of its impact on populations, including those most affected by the morbidity and mortality of smoking-related illness and lung cancer. As such, this book emphasizes a number of important public health topics, including community outreach to vulnerable populations, social justice issues, addressing stigma and fatalism in the general community, and the use of geocoding to assess a program?s impact at a population level. This book weaves traditional topics related to lung cancer screening, such as promoting initial and repeat screening, interpreting Lung RADs, and managing the follow-up of findings, into the population perspective in order to present a unified, comprehensive approach to the subject. Further, it serves as a guide that health systems, health care professionals, community leaders, and other stakeholders can use to achieve the promise of lung cancer screening.


SECTION 1: INTRODUCTION
Chapter 1: The Promise of Lung Cancer Screening
Chapter 2: A Brief History of Lung Cancer Screening
Chapter 3: Stigma and Fatalism in Lung Cancer
Chapter 4: Screening Eligibility, Education, and Shared Decision Making
Chapter 5: Smoking Cessation in a Lung Cancer Screening Program
Chapter 6: Why Achieving Health Equity in Lung Cancer Screening is So
SECTION 2: APPLYING A LEARNING COMMUNITY MODEL
Chapter 7: A Health System Learning Community
Chapter 8: Different Approaches for Offering Lung Cancer Screening
Chapter 9: Identifying Patients Eligible for Lung Cancer Screening
Chapter 10: Patient Outreach and Provider Support in Lung Cancer Screening
Chapter 11: Shared Decision Making in Lung Cancer Screening
Chapter 12: Advances in Tobacco Treatment
SECTION 3: ORGANIZING A QUALITY PROGRAM
Chapter 13: Organizational Workflow for Lung Cancer
Chapter 14: Lung-RADS and Radiology Reporting Requirements
Chapter 15: Managing Incidental Findings
Chapter 16: Leveraging the EMR for Continuous Quality
Chapter 17: Minimizing Harms of Screening
Chapter 18: A Multidisciplinary Approach
Chapter 19: Managing Lung Cancer Screening in a Major Health Care System
Chapter 20: Cost Considerations
SECTION 4: TAKING CARE OF THE PATIENT
Chapter 21: Engaging Patients from Diverse Backgrounds in Lung Cancer
Chapter 22: Modern Management of Early-Stage Lung Cancer
Chapter 23: The Revolution of Lung Cancer Therapeutics
SECTION 5: ENGAGING THE COMMUNITY
Chapter 24: Lung Cancer and Social Justice – What Do I Need to Understand?
Chapter 25: Reaching Vulnerable Populations and Areas of Need
Chapter 26: Lung Cancer Myths and How Do I Address Them?
Chapter 27: How to Expand Your Program’s Reach Beyond the Healthcare System and Into the Community
SECTION 6: DETERMINING IMPACT AT THE POPULATION LEVEL
Chapter 28: Lung Cancer Screening–Addressing  Disparities
Chapter 29: Geocoding and Assessing a Program’s Impact
Chapter 30: Partnering with Stakeholders for Broad Impact
SECTION 7: ON THE HORIZON: WHAT LIES AHEAD IN LUNG CANCER SCREENING
Chapter 31: Assessing Health Systems’ Preparedness for Addressing Lung Cancer Screening at a Population Level Chapter 32: New Partnerships in Reaching Unique Populations
Chapter 33: Where Do We Go From Here?
Chapter 34: Imaging an Equitable Lung Cancer Screening

Gregory C. Kane, MD, MACP                                                                                           

The Jefferson-National Jewish Health Korman Respiratory Institute

Division of Pulmonary and Critical Care Medicine

Department of Medicine

Sidney Kimmel Medical College at Thomas Jefferson University

Philadelphia, PA, USA                                                                                                     


Julie A. Barta, MD, ATSF

The Jefferson-National Jewish Health Korman Respiratory Institute

Division of Pulmonary and Critical Care Medicine

Department of Medicine

Sidney Kimmel Medical College at Thomas Jefferson University      

Philadelphia, PA, USA

 

Ronald E. Myers, DSW, PhD, FSBM                                                                                                     

Division of Population Science 

Department of Medical Oncology

Sidney Kimmel Cancer Center at Thomas Jefferson University                    

Philadelphia, PA, USA                   

Reviews lung cancer screening through the lens of social justice and community impact

Discusses the multidisciplinary coordination implementation of lung cancer screening across health systems

Describes the process and mechanisms essential to running an effective lung cancer screening program

Date de parution :

Ouvrage de 390 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 137,14 €

Ajouter au panier

Thème de Lung Cancer Screening  :